Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 4.67738025 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.48851761 |
3 | glutamate secretion (GO:0014047) | 4.17969799 |
4 | synaptic vesicle exocytosis (GO:0016079) | 4.08295339 |
5 | locomotory exploration behavior (GO:0035641) | 4.06069871 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.05515763 |
7 | L-amino acid import (GO:0043092) | 3.96095484 |
8 | amino acid import (GO:0043090) | 3.83270526 |
9 | cerebellar granule cell differentiation (GO:0021707) | 3.82823788 |
10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.79654072 |
11 | neurotransmitter secretion (GO:0007269) | 3.74173866 |
12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.73009919 |
13 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.70750567 |
14 | L-phenylalanine catabolic process (GO:0006559) | 3.65787899 |
15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.65787899 |
16 | vocalization behavior (GO:0071625) | 3.63166066 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.61484114 |
18 | neuronal ion channel clustering (GO:0045161) | 3.55519946 |
19 | L-phenylalanine metabolic process (GO:0006558) | 3.54547219 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.54547219 |
21 | regulation of synaptic vesicle transport (GO:1902803) | 3.43080974 |
22 | gamma-aminobutyric acid transport (GO:0015812) | 3.42759982 |
23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.39418110 |
24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.39201254 |
25 | regulation of ARF protein signal transduction (GO:0032012) | 3.37142545 |
26 | positive regulation of synapse maturation (GO:0090129) | 3.31365870 |
27 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.29592694 |
28 | neuronal action potential propagation (GO:0019227) | 3.28541914 |
29 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.24306906 |
30 | regulation of synapse structural plasticity (GO:0051823) | 3.24043419 |
31 | potassium ion import (GO:0010107) | 3.20340121 |
32 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.18474445 |
33 | potassium ion homeostasis (GO:0055075) | 3.18160159 |
34 | proline transport (GO:0015824) | 3.15989489 |
35 | exploration behavior (GO:0035640) | 3.14914882 |
36 | glutamate metabolic process (GO:0006536) | 3.13959961 |
37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.12889396 |
38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.12315140 |
39 | aromatic amino acid family catabolic process (GO:0009074) | 3.09545029 |
40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09358275 |
41 | cell communication involved in cardiac conduction (GO:0086065) | 3.07426091 |
42 | cellular potassium ion homeostasis (GO:0030007) | 3.07416398 |
43 | lysine metabolic process (GO:0006553) | 3.06949582 |
44 | lysine catabolic process (GO:0006554) | 3.06949582 |
45 | activation of protein kinase A activity (GO:0034199) | 3.06929322 |
46 | protein localization to synapse (GO:0035418) | 3.06118194 |
47 | neurotransmitter transport (GO:0006836) | 3.06036130 |
48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02003199 |
49 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.01934347 |
50 | neuromuscular process controlling posture (GO:0050884) | 3.01803281 |
51 | sodium ion export (GO:0071436) | 2.98152909 |
52 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97386150 |
53 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.96441448 |
54 | regulation of neurotransmitter levels (GO:0001505) | 2.94655668 |
55 | detection of calcium ion (GO:0005513) | 2.94463208 |
56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.93092812 |
57 | synaptic vesicle endocytosis (GO:0048488) | 2.92549870 |
58 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.91122166 |
59 | regulation of cell communication by electrical coupling (GO:0010649) | 2.90077016 |
60 | layer formation in cerebral cortex (GO:0021819) | 2.88962417 |
61 | positive regulation of dendritic spine development (GO:0060999) | 2.88717432 |
62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.87808752 |
63 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.85299101 |
64 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.81042256 |
65 | bile acid biosynthetic process (GO:0006699) | 2.79795293 |
66 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.79367970 |
67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.79049399 |
68 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.77831326 |
69 | cellular ketone body metabolic process (GO:0046950) | 2.77197808 |
70 | cysteine metabolic process (GO:0006534) | 2.76856053 |
71 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.74982976 |
72 | postsynaptic membrane organization (GO:0001941) | 2.74192791 |
73 | regulation of neurotransmitter transport (GO:0051588) | 2.72964343 |
74 | regulation of synapse maturation (GO:0090128) | 2.72041638 |
75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.71713558 |
76 | alpha-linolenic acid metabolic process (GO:0036109) | 2.71638366 |
77 | dicarboxylic acid catabolic process (GO:0043649) | 2.70283108 |
78 | kynurenine metabolic process (GO:0070189) | 2.69592982 |
79 | glycine transport (GO:0015816) | 2.67347333 |
80 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.67289201 |
81 | glyoxylate metabolic process (GO:0046487) | 2.66681947 |
82 | positive regulation of membrane potential (GO:0045838) | 2.66102251 |
83 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.65483343 |
84 | cell communication by electrical coupling (GO:0010644) | 2.64477214 |
85 | drug catabolic process (GO:0042737) | 2.64376452 |
86 | alanine transport (GO:0032328) | 2.63770344 |
87 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63111648 |
88 | membrane depolarization during action potential (GO:0086010) | 2.62657608 |
89 | exogenous drug catabolic process (GO:0042738) | 2.61977989 |
90 | cellular response to catecholamine stimulus (GO:0071870) | 2.61753592 |
91 | cellular response to monoamine stimulus (GO:0071868) | 2.61753592 |
92 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.61283016 |
93 | synaptic transmission, glutamatergic (GO:0035249) | 2.61210198 |
94 | aspartate family amino acid catabolic process (GO:0009068) | 2.59818642 |
95 | acidic amino acid transport (GO:0015800) | 2.59590631 |
96 | neuron-neuron synaptic transmission (GO:0007270) | 2.59110548 |
97 | neuron cell-cell adhesion (GO:0007158) | 2.58658163 |
98 | indole-containing compound catabolic process (GO:0042436) | 2.58621134 |
99 | indolalkylamine catabolic process (GO:0046218) | 2.58621134 |
100 | tryptophan catabolic process (GO:0006569) | 2.58621134 |
101 | prepulse inhibition (GO:0060134) | 2.56126833 |
102 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.55742022 |
103 | cellular modified amino acid catabolic process (GO:0042219) | 2.55602344 |
104 | drug transmembrane transport (GO:0006855) | 2.55589133 |
105 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.54439586 |
106 | neuromuscular process controlling balance (GO:0050885) | 2.53284484 |
107 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.52505062 |
108 | long-term memory (GO:0007616) | 2.52175690 |
109 | regulation of synaptic plasticity (GO:0048167) | 2.50613209 |
110 | behavioral response to cocaine (GO:0048148) | 2.49103945 |
111 | cellular response to epinephrine stimulus (GO:0071872) | 2.48924298 |
112 | cellular sodium ion homeostasis (GO:0006883) | 2.47532963 |
113 | short-chain fatty acid metabolic process (GO:0046459) | 2.47196090 |
114 | glutamate receptor signaling pathway (GO:0007215) | 2.46659649 |
115 | regulation of synaptic transmission (GO:0050804) | 2.45236938 |
116 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.45133129 |
117 | mating behavior (GO:0007617) | 2.43995113 |
118 | dendritic spine organization (GO:0097061) | 2.43352933 |
119 | sulfur amino acid catabolic process (GO:0000098) | 2.43235109 |
120 | clathrin coat assembly (GO:0048268) | 2.41827542 |
121 | succinate metabolic process (GO:0006105) | 2.41719391 |
122 | membrane depolarization (GO:0051899) | 2.41006271 |
123 | regulation of postsynaptic membrane potential (GO:0060078) | 2.40952328 |
124 | regulation of female receptivity (GO:0045924) | 2.40224990 |
125 | cardiac muscle contraction (GO:0060048) | 2.39763472 |
126 | ketone body metabolic process (GO:1902224) | 2.39723766 |
127 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.39632163 |
128 | tryptophan metabolic process (GO:0006568) | 2.39020530 |
129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.37276438 |
130 | regulation of dendritic spine development (GO:0060998) | 2.36946535 |
131 | regulation of neurotransmitter secretion (GO:0046928) | 2.36068382 |
132 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35695144 |
133 | central nervous system myelination (GO:0022010) | 2.35345768 |
134 | axon ensheathment in central nervous system (GO:0032291) | 2.35345768 |
135 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.34379206 |
136 | neuromuscular process (GO:0050905) | 2.34324166 |
137 | coenzyme catabolic process (GO:0009109) | 2.32897156 |
138 | regulation of vesicle fusion (GO:0031338) | 2.32686787 |
139 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.32195441 |
140 | positive regulation of neurotransmitter transport (GO:0051590) | 2.30810139 |
141 | dendritic spine morphogenesis (GO:0060997) | 2.30452460 |
142 | long-term synaptic potentiation (GO:0060291) | 2.29919067 |
143 | alpha-amino acid catabolic process (GO:1901606) | 2.28451003 |
144 | bile acid metabolic process (GO:0008206) | 2.27118267 |
145 | 2-oxoglutarate metabolic process (GO:0006103) | 2.27065976 |
146 | cellular amino acid catabolic process (GO:0009063) | 2.26888824 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91634945 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.49356260 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61246349 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58299824 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50253642 |
6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48907524 |
7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31729167 |
8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30111622 |
9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29869120 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.29472762 |
11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25541028 |
12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25541028 |
13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.24273798 |
14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22073479 |
15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.16726519 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12734005 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12251269 |
18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07002717 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05313965 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99893908 |
21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98752058 |
22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94778196 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94437329 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90225704 |
25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88207396 |
26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.80281476 |
27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78371935 |
28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77362681 |
29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.76347962 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.74908820 |
31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61377437 |
32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59318137 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58692110 |
34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58387669 |
35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58058961 |
36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56525355 |
37 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53106797 |
38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53072280 |
39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.48535230 |
40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48371416 |
41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41436468 |
42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.36593955 |
43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35928932 |
44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33361974 |
45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30192501 |
46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28461898 |
47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28387865 |
48 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28353352 |
49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28231032 |
50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28230923 |
51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23476617 |
52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23246438 |
53 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.19781787 |
54 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19742487 |
55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18551546 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16091736 |
57 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10798812 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10688967 |
59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09787415 |
60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07900344 |
61 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07806458 |
62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07582503 |
63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07207274 |
64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05854734 |
65 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.05310176 |
66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04863827 |
67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03386211 |
68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03251425 |
69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03194448 |
70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02959915 |
71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02358225 |
72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02314193 |
73 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01622366 |
74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01058264 |
75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01022074 |
76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00992251 |
77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00535944 |
78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00449119 |
79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99733326 |
80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99607593 |
81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98766510 |
82 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98419852 |
83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98415998 |
84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98371716 |
85 | AR_19668381_ChIP-Seq_PC3_Human | 0.96424733 |
86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96413172 |
87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96413172 |
88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95670060 |
89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95004019 |
90 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93688091 |
91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93462403 |
92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92768029 |
93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92370044 |
94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92100104 |
95 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91750676 |
96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91618794 |
97 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91227853 |
98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89925472 |
99 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89679262 |
100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88820197 |
101 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87380422 |
102 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86865771 |
103 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86487704 |
104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86466348 |
105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86352881 |
106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85873993 |
107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85599168 |
108 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85339458 |
109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84910016 |
110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84372131 |
111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84091967 |
112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83106915 |
113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82985407 |
114 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82627466 |
115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82579735 |
116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82086219 |
117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81940728 |
118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81652726 |
119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81641084 |
120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81516425 |
121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81485575 |
122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80530008 |
123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80246308 |
124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80097136 |
125 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79463113 |
126 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79140485 |
127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79057527 |
128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78752445 |
129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78488251 |
130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78408325 |
131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77646053 |
132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77571078 |
133 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.76769903 |
134 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75871900 |
135 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75848282 |
136 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75848282 |
137 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.75491897 |
138 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.74956839 |
139 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74446295 |
140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.73515329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.06533218 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.84034018 |
3 | MP0005360_urolithiasis | 3.47856413 |
4 | MP0002822_catalepsy | 3.22966253 |
5 | MP0003880_abnormal_central_pattern | 3.20546843 |
6 | MP0003635_abnormal_synaptic_transmissio | 3.16411652 |
7 | MP0004270_analgesia | 2.92196572 |
8 | MP0005085_abnormal_gallbladder_physiolo | 2.79172942 |
9 | MP0009745_abnormal_behavioral_response | 2.66695190 |
10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55491957 |
11 | MP0005365_abnormal_bile_salt | 2.53154022 |
12 | MP0002063_abnormal_learning/memory/cond | 2.51963536 |
13 | MP0002064_seizures | 2.51528463 |
14 | MP0001968_abnormal_touch/_nociception | 2.40691279 |
15 | MP0009046_muscle_twitch | 2.32853711 |
16 | MP0003329_amyloid_beta_deposits | 2.14870593 |
17 | MP0002572_abnormal_emotion/affect_behav | 2.06826188 |
18 | MP0002272_abnormal_nervous_system | 2.00528534 |
19 | MP0001501_abnormal_sleep_pattern | 2.00228387 |
20 | MP0002734_abnormal_mechanical_nocicepti | 1.94615989 |
21 | MP0003195_calcinosis | 1.91044141 |
22 | MP0002909_abnormal_adrenal_gland | 1.90859399 |
23 | MP0002735_abnormal_chemical_nociception | 1.86489058 |
24 | MP0002736_abnormal_nociception_after | 1.85638881 |
25 | MP0004510_myositis | 1.84315238 |
26 | MP0001486_abnormal_startle_reflex | 1.83686245 |
27 | MP0004858_abnormal_nervous_system | 1.82510128 |
28 | MP0009780_abnormal_chondrocyte_physiolo | 1.81205597 |
29 | MP0005332_abnormal_amino_acid | 1.76357813 |
30 | MP0002733_abnormal_thermal_nociception | 1.74559580 |
31 | MP0010329_abnormal_lipoprotein_level | 1.71959680 |
32 | MP0004043_abnormal_pH_regulation | 1.68778186 |
33 | MP0005423_abnormal_somatic_nervous | 1.67987311 |
34 | MP0003252_abnormal_bile_duct | 1.63285689 |
35 | MP0001440_abnormal_grooming_behavior | 1.61359926 |
36 | MP0006276_abnormal_autonomic_nervous | 1.56765015 |
37 | MP0001970_abnormal_pain_threshold | 1.54041677 |
38 | MP0005646_abnormal_pituitary_gland | 1.52744774 |
39 | MP0005535_abnormal_body_temperature | 1.50280534 |
40 | MP0002067_abnormal_sensory_capabilities | 1.43691709 |
41 | MP0000749_muscle_degeneration | 1.41272632 |
42 | MP0000604_amyloidosis | 1.39710452 |
43 | MP0003879_abnormal_hair_cell | 1.34377030 |
44 | MP0003633_abnormal_nervous_system | 1.34305879 |
45 | MP0004924_abnormal_behavior | 1.34172540 |
46 | MP0005386_behavior/neurological_phenoty | 1.34172540 |
47 | MP0004885_abnormal_endolymph | 1.34070791 |
48 | MP0004036_abnormal_muscle_relaxation | 1.33669067 |
49 | MP0008569_lethality_at_weaning | 1.31586442 |
50 | MP0005083_abnormal_biliary_tract | 1.30956505 |
51 | MP0004811_abnormal_neuron_physiology | 1.29917853 |
52 | MP0001984_abnormal_olfaction | 1.28436628 |
53 | MP0003075_altered_response_to | 1.23607402 |
54 | MP0004084_abnormal_cardiac_muscle | 1.23432028 |
55 | MP0003634_abnormal_glial_cell | 1.22463225 |
56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20811590 |
57 | MP0004019_abnormal_vitamin_homeostasis | 1.20442920 |
58 | MP0008872_abnormal_physiological_respon | 1.19647133 |
59 | MP0002557_abnormal_social/conspecific_i | 1.19482818 |
60 | MP0004484_altered_response_of | 1.18703324 |
61 | MP0002118_abnormal_lipid_homeostasis | 1.18475496 |
62 | MP0002837_dystrophic_cardiac_calcinosis | 1.18373427 |
63 | MP0008961_abnormal_basal_metabolism | 1.16565896 |
64 | MP0008874_decreased_physiological_sensi | 1.15482253 |
65 | MP0003690_abnormal_glial_cell | 1.15073815 |
66 | MP0001348_abnormal_lacrimal_gland | 1.14026263 |
67 | MP0001958_emphysema | 1.11729931 |
68 | MP0001765_abnormal_ion_homeostasis | 1.10740070 |
69 | MP0000747_muscle_weakness | 1.10312558 |
70 | MP0002066_abnormal_motor_capabilities/c | 1.09996976 |
71 | MP0000013_abnormal_adipose_tissue | 1.09695217 |
72 | MP0004130_abnormal_muscle_cell | 1.09519632 |
73 | MP0000955_abnormal_spinal_cord | 1.07672687 |
74 | MP0005623_abnormal_meninges_morphology | 1.05244981 |
75 | MP0002184_abnormal_innervation | 1.04468600 |
76 | MP0002295_abnormal_pulmonary_circulatio | 1.04277212 |
77 | MP0001502_abnormal_circadian_rhythm | 1.03560536 |
78 | MP0002876_abnormal_thyroid_physiology | 1.03161095 |
79 | MP0003631_nervous_system_phenotype | 1.03014507 |
80 | MP0003705_abnormal_hypodermis_morpholog | 1.00857794 |
81 | MP0004215_abnormal_myocardial_fiber | 1.00726581 |
82 | MP0004087_abnormal_muscle_fiber | 1.00537887 |
83 | MP0008260_abnormal_autophagy | 0.99125031 |
84 | MP0004142_abnormal_muscle_tone | 0.98455289 |
85 | MP0005058_abnormal_lysosome_morphology | 0.97366180 |
86 | MP0008438_abnormal_cutaneous_collagen | 0.96542237 |
87 | MP0001666_abnormal_nutrient_absorption | 0.96204485 |
88 | MP0005167_abnormal_blood-brain_barrier | 0.95963696 |
89 | MP0002069_abnormal_eating/drinking_beha | 0.95440037 |
90 | MP0001905_abnormal_dopamine_level | 0.95369749 |
91 | MP0009840_abnormal_foam_cell | 0.95014452 |
92 | MP0006138_congestive_heart_failure | 0.92359771 |
93 | MP0003191_abnormal_cellular_cholesterol | 0.92326346 |
94 | MP0002972_abnormal_cardiac_muscle | 0.92163804 |
95 | MP0003279_aneurysm | 0.91985326 |
96 | MP0003632_abnormal_nervous_system | 0.91855748 |
97 | MP0002882_abnormal_neuron_morphology | 0.89766841 |
98 | MP0002229_neurodegeneration | 0.89629344 |
99 | MP0005620_abnormal_muscle_contractility | 0.88418017 |
100 | MP0000759_abnormal_skeletal_muscle | 0.86833784 |
101 | MP0002090_abnormal_vision | 0.86160707 |
102 | MP0005166_decreased_susceptibility_to | 0.85763419 |
103 | MP0001756_abnormal_urination | 0.83853431 |
104 | MP0003828_pulmonary_edema | 0.83135970 |
105 | MP0010386_abnormal_urinary_bladder | 0.82726434 |
106 | MP0005636_abnormal_mineral_homeostasis | 0.82579189 |
107 | MP0003122_maternal_imprinting | 0.82328404 |
108 | MP0002138_abnormal_hepatobiliary_system | 0.82109583 |
109 | MP0008004_abnormal_stomach_pH | 0.81202731 |
110 | MP0002078_abnormal_glucose_homeostasis | 0.80792744 |
111 | MP0000750_abnormal_muscle_regeneration | 0.79870053 |
112 | MP0000751_myopathy | 0.79366644 |
113 | MP0000343_altered_response_to | 0.79240905 |
114 | MP0003868_abnormal_feces_composition | 0.78816768 |
115 | MP0005670_abnormal_white_adipose | 0.78771217 |
116 | MP0000778_abnormal_nervous_system | 0.78688226 |
117 | MP0002332_abnormal_exercise_endurance | 0.78211526 |
118 | MP0003137_abnormal_impulse_conducting | 0.77401187 |
119 | MP0003787_abnormal_imprinting | 0.77146860 |
120 | MP0009643_abnormal_urine_homeostasis | 0.76873679 |
121 | MP0000230_abnormal_systemic_arterial | 0.76555367 |
122 | MP0005645_abnormal_hypothalamus_physiol | 0.75484021 |
123 | MP0002269_muscular_atrophy | 0.75243000 |
124 | MP0005319_abnormal_enzyme/_coenzyme | 0.75234394 |
125 | MP0003806_abnormal_nucleotide_metabolis | 0.74429536 |
126 | MP0001177_atelectasis | 0.72808146 |
127 | MP0003091_abnormal_cell_migration | 0.72529451 |
128 | MP0001529_abnormal_vocalization | 0.72005644 |
129 | MP0003172_abnormal_lysosome_physiology | 0.71461248 |
130 | MP0005409_darkened_coat_color | 0.71371330 |
131 | MP0005595_abnormal_vascular_smooth | 0.71166480 |
132 | MP0002152_abnormal_brain_morphology | 0.70370813 |
133 | MP0002133_abnormal_respiratory_system | 0.69617242 |
134 | MP0005388_respiratory_system_phenotype | 0.69617242 |
135 | MP0003283_abnormal_digestive_organ | 0.68334684 |
136 | MP0002971_abnormal_brown_adipose | 0.67982702 |
137 | MP0005551_abnormal_eye_electrophysiolog | 0.67319734 |
138 | MP0000920_abnormal_myelination | 0.66624143 |
139 | MP0003953_abnormal_hormone_level | 0.66580902 |
140 | MP0004085_abnormal_heartbeat | 0.66260183 |
141 | MP0005084_abnormal_gallbladder_morpholo | 0.65597723 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.66056804 |
2 | Focal motor seizures (HP:0011153) | 5.01222302 |
3 | Visual hallucinations (HP:0002367) | 3.87563232 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.85748645 |
5 | Focal seizures (HP:0007359) | 3.84769029 |
6 | Diplopia (HP:0000651) | 3.63611849 |
7 | Abnormality of binocular vision (HP:0011514) | 3.63611849 |
8 | Gout (HP:0001997) | 3.44029502 |
9 | Deep venous thrombosis (HP:0002625) | 3.23126172 |
10 | Action tremor (HP:0002345) | 3.10311084 |
11 | Bundle branch block (HP:0011710) | 3.09068915 |
12 | Obstructive sleep apnea (HP:0002870) | 3.06238616 |
13 | Increased circulating renin level (HP:0000848) | 3.01839676 |
14 | Ketosis (HP:0001946) | 2.98536152 |
15 | Supranuclear gaze palsy (HP:0000605) | 2.93693336 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 2.93046298 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 2.93025294 |
18 | Xanthomatosis (HP:0000991) | 2.92597861 |
19 | Atonic seizures (HP:0010819) | 2.91184397 |
20 | Ketoacidosis (HP:0001993) | 2.85751153 |
21 | Absence seizures (HP:0002121) | 2.85108767 |
22 | Torticollis (HP:0000473) | 2.83680250 |
23 | Epileptic encephalopathy (HP:0200134) | 2.79126933 |
24 | Anxiety (HP:0000739) | 2.78223910 |
25 | Intrahepatic cholestasis (HP:0001406) | 2.78087566 |
26 | Status epilepticus (HP:0002133) | 2.75012696 |
27 | Neuronal loss in central nervous system (HP:0002529) | 2.74875326 |
28 | Hyperventilation (HP:0002883) | 2.73582062 |
29 | Abnormal eating behavior (HP:0100738) | 2.72193163 |
30 | Sudden death (HP:0001699) | 2.71503503 |
31 | Focal dystonia (HP:0004373) | 2.71466614 |
32 | Febrile seizures (HP:0002373) | 2.66574295 |
33 | Pheochromocytoma (HP:0002666) | 2.64171974 |
34 | Muscle fiber splitting (HP:0003555) | 2.64037303 |
35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63849956 |
36 | Craniofacial dystonia (HP:0012179) | 2.63632778 |
37 | Postural instability (HP:0002172) | 2.60708258 |
38 | Depression (HP:0000716) | 2.60306885 |
39 | Progressive cerebellar ataxia (HP:0002073) | 2.60042917 |
40 | Ankle clonus (HP:0011448) | 2.58950432 |
41 | Rapidly progressive (HP:0003678) | 2.55660870 |
42 | Dialeptic seizures (HP:0011146) | 2.54037278 |
43 | Abnormal social behavior (HP:0012433) | 2.53739288 |
44 | Impaired social interactions (HP:0000735) | 2.53739288 |
45 | Annular pancreas (HP:0001734) | 2.53614873 |
46 | Hypokalemic alkalosis (HP:0001949) | 2.51256931 |
47 | Foot dorsiflexor weakness (HP:0009027) | 2.50638671 |
48 | Hyperlipoproteinemia (HP:0010980) | 2.50150077 |
49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.48861154 |
50 | Poor eye contact (HP:0000817) | 2.48724000 |
51 | Lower limb muscle weakness (HP:0007340) | 2.47942506 |
52 | Lower limb amyotrophy (HP:0007210) | 2.46683399 |
53 | Apathy (HP:0000741) | 2.46405438 |
54 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.46285770 |
55 | Abnormality of the lower motor neuron (HP:0002366) | 2.43841199 |
56 | Heart block (HP:0012722) | 2.42451261 |
57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.40303905 |
58 | Abnormality of the foot musculature (HP:0001436) | 2.39235510 |
59 | Neurofibrillary tangles (HP:0002185) | 2.38960256 |
60 | Abnormal atrioventricular conduction (HP:0005150) | 2.38810762 |
61 | Hyperammonemia (HP:0001987) | 2.38025096 |
62 | Metabolic alkalosis (HP:0200114) | 2.37448361 |
63 | Neonatal onset (HP:0003623) | 2.37225878 |
64 | Hyperglycinuria (HP:0003108) | 2.34403249 |
65 | Complement deficiency (HP:0004431) | 2.32011920 |
66 | Peripheral hypomyelination (HP:0007182) | 2.30427993 |
67 | Alkalosis (HP:0001948) | 2.30401975 |
68 | Asymmetric septal hypertrophy (HP:0001670) | 2.29588187 |
69 | Cerebral inclusion bodies (HP:0100314) | 2.28588998 |
70 | Hyperglycinemia (HP:0002154) | 2.27636747 |
71 | Neuroendocrine neoplasm (HP:0100634) | 2.27295179 |
72 | Diminished motivation (HP:0000745) | 2.24558031 |
73 | Dysdiadochokinesis (HP:0002075) | 2.24237875 |
74 | Sensorimotor neuropathy (HP:0007141) | 2.24206066 |
75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.23909408 |
76 | Abnormality of glycine metabolism (HP:0010895) | 2.23909408 |
77 | Delayed CNS myelination (HP:0002188) | 2.21612048 |
78 | Atrioventricular block (HP:0001678) | 2.20608277 |
79 | Abnormal gallbladder physiology (HP:0012438) | 2.19999683 |
80 | Cholecystitis (HP:0001082) | 2.19999683 |
81 | Intention tremor (HP:0002080) | 2.18692965 |
82 | Dysmetria (HP:0001310) | 2.17890431 |
83 | Hyperactive renin-angiotensin system (HP:0000841) | 2.15890125 |
84 | EMG: myopathic abnormalities (HP:0003458) | 2.11327609 |
85 | Prolonged partial thromboplastin time (HP:0003645) | 2.10198349 |
86 | Abnormality of purine metabolism (HP:0004352) | 2.08417940 |
87 | Difficulty running (HP:0009046) | 2.08174576 |
88 | Bradykinesia (HP:0002067) | 2.07434866 |
89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07196353 |
90 | Hypobetalipoproteinemia (HP:0003563) | 2.05064741 |
91 | Atrial fibrillation (HP:0005110) | 2.04802892 |
92 | Urinary urgency (HP:0000012) | 2.03923921 |
93 | Primary atrial arrhythmia (HP:0001692) | 2.02199507 |
94 | Scanning speech (HP:0002168) | 2.02057249 |
95 | Clonus (HP:0002169) | 2.01600695 |
96 | Type 1 muscle fiber predominance (HP:0003803) | 2.01312759 |
97 | Protrusio acetabuli (HP:0003179) | 2.01240129 |
98 | Truncal ataxia (HP:0002078) | 2.01191145 |
99 | Upper limb amyotrophy (HP:0009129) | 2.01180775 |
100 | Distal upper limb amyotrophy (HP:0007149) | 2.01180775 |
101 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00905067 |
102 | Exercise-induced myalgia (HP:0003738) | 2.00436529 |
103 | Increased purine levels (HP:0004368) | 1.95730327 |
104 | Hyperuricemia (HP:0002149) | 1.95730327 |
105 | Papilledema (HP:0001085) | 1.95207048 |
106 | Polyphagia (HP:0002591) | 1.94471728 |
107 | Syncope (HP:0001279) | 1.94087273 |
108 | Slow progression (HP:0003677) | 1.94063942 |
109 | Delusions (HP:0000746) | 1.93502438 |
110 | Supraventricular tachycardia (HP:0004755) | 1.93378160 |
111 | Hypomagnesemia (HP:0002917) | 1.93115195 |
112 | Distal lower limb amyotrophy (HP:0008944) | 1.92543781 |
113 | Spastic gait (HP:0002064) | 1.91615692 |
114 | Epidermoid cyst (HP:0200040) | 1.91389507 |
115 | Agitation (HP:0000713) | 1.91378761 |
116 | Slow saccadic eye movements (HP:0000514) | 1.90929955 |
117 | Supraventricular arrhythmia (HP:0005115) | 1.90760865 |
118 | Cerebral hypomyelination (HP:0006808) | 1.90494920 |
119 | Hypercortisolism (HP:0001578) | 1.89785269 |
120 | Decreased motor nerve conduction velocity (HP:0003431) | 1.89766848 |
121 | Abnormality of the corticospinal tract (HP:0002492) | 1.89688292 |
122 | Hammertoe (HP:0001765) | 1.88641067 |
123 | Mutism (HP:0002300) | 1.88336410 |
124 | Ventricular fibrillation (HP:0001663) | 1.87372606 |
125 | Progressive inability to walk (HP:0002505) | 1.87203878 |
126 | Amblyopia (HP:0000646) | 1.86909446 |
127 | Impaired vibratory sensation (HP:0002495) | 1.85802630 |
128 | Scapular winging (HP:0003691) | 1.84814971 |
129 | Epileptiform EEG discharges (HP:0011182) | 1.84451823 |
130 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83889582 |
131 | Sleep apnea (HP:0010535) | 1.83692407 |
132 | Turricephaly (HP:0000262) | 1.83530057 |
133 | Hypsarrhythmia (HP:0002521) | 1.82615359 |
134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82449894 |
135 | Amyloidosis (HP:0011034) | 1.82398544 |
136 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82374923 |
137 | Distal lower limb muscle weakness (HP:0009053) | 1.82164194 |
138 | Hand muscle atrophy (HP:0009130) | 1.81504628 |
139 | Aortic aneurysm (HP:0004942) | 1.81291799 |
140 | Gaze-evoked nystagmus (HP:0000640) | 1.80593429 |
141 | Resting tremor (HP:0002322) | 1.80294519 |
142 | Frequent falls (HP:0002359) | 1.80069687 |
143 | Rigidity (HP:0002063) | 1.79243986 |
144 | Tetraplegia (HP:0002445) | 1.79156177 |
145 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77663702 |
146 | Limb dystonia (HP:0002451) | 1.77618765 |
147 | Abnormal urine output (HP:0012590) | 1.77379114 |
148 | Irritability (HP:0000737) | 1.77350269 |
149 | Dysmetric saccades (HP:0000641) | 1.77119307 |
150 | Cerebral hemorrhage (HP:0001342) | 1.76727460 |
151 | Global brain atrophy (HP:0002283) | 1.76146050 |
152 | Broad-based gait (HP:0002136) | 1.76057080 |
153 | Hyperaldosteronism (HP:0000859) | 1.75750066 |
154 | Hemiplegia (HP:0002301) | 1.75629256 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.82492714 |
2 | EPHA4 | 3.79708980 |
3 | MAP3K9 | 3.52569858 |
4 | DAPK2 | 2.62005508 |
5 | MAP3K4 | 2.58178861 |
6 | MINK1 | 2.56507440 |
7 | KSR2 | 2.52800859 |
8 | MAP2K4 | 2.39114325 |
9 | NTRK1 | 2.19202384 |
10 | MAP3K12 | 2.08820185 |
11 | MAP2K7 | 2.05487179 |
12 | PRKD3 | 1.95763830 |
13 | PAK6 | 1.93716470 |
14 | CAMKK1 | 1.91372579 |
15 | ARAF | 1.88658609 |
16 | WNK4 | 1.85793208 |
17 | MARK1 | 1.76732896 |
18 | WNK3 | 1.76296949 |
19 | OXSR1 | 1.76112373 |
20 | MAP3K2 | 1.57590825 |
21 | PINK1 | 1.54595392 |
22 | GRK5 | 1.50224754 |
23 | STK38 | 1.46151942 |
24 | MAP3K13 | 1.43588459 |
25 | MYLK | 1.42097770 |
26 | RIPK4 | 1.40217623 |
27 | NTRK2 | 1.38012168 |
28 | DAPK1 | 1.33557606 |
29 | CDK5 | 1.33101113 |
30 | SGK494 | 1.29547953 |
31 | SGK223 | 1.29547953 |
32 | KSR1 | 1.20436897 |
33 | LMTK2 | 1.19163028 |
34 | TTN | 1.18543759 |
35 | BCKDK | 1.16988706 |
36 | CAMKK2 | 1.12937678 |
37 | RET | 1.11935586 |
38 | PRKCG | 1.11483318 |
39 | CDK19 | 1.10763772 |
40 | TESK1 | 1.06733402 |
41 | MAP3K1 | 1.06491169 |
42 | PRKCH | 1.01252490 |
43 | FES | 0.97675180 |
44 | SGK3 | 0.96456970 |
45 | TAOK1 | 0.95269088 |
46 | SGK2 | 0.95132755 |
47 | OBSCN | 0.94749501 |
48 | TRIB3 | 0.94143200 |
49 | NEK6 | 0.94122807 |
50 | LATS2 | 0.92967882 |
51 | PHKG1 | 0.92352299 |
52 | PHKG2 | 0.92352299 |
53 | PDPK1 | 0.90704785 |
54 | PDGFRA | 0.90079395 |
55 | PDK2 | 0.88657525 |
56 | PAK3 | 0.85714508 |
57 | NEK1 | 0.85599907 |
58 | MOS | 0.84362675 |
59 | SIK2 | 0.83121582 |
60 | PTK2B | 0.82924799 |
61 | PDK1 | 0.81975918 |
62 | CAMK1 | 0.81876999 |
63 | CAMK2A | 0.79957318 |
64 | UHMK1 | 0.78098785 |
65 | DYRK1A | 0.78043618 |
66 | MAP2K1 | 0.77371185 |
67 | STK39 | 0.76962298 |
68 | TYRO3 | 0.74381237 |
69 | RIPK1 | 0.72590379 |
70 | MAP3K7 | 0.71341286 |
71 | PLK2 | 0.70939885 |
72 | DDR2 | 0.70534002 |
73 | AKT3 | 0.69314092 |
74 | PRKCZ | 0.69192192 |
75 | FER | 0.68781370 |
76 | LIMK1 | 0.68551220 |
77 | RAF1 | 0.67677977 |
78 | DMPK | 0.66929444 |
79 | PRPF4B | 0.66733549 |
80 | STK11 | 0.64587254 |
81 | WNK1 | 0.64263013 |
82 | TNIK | 0.62947618 |
83 | CAMK2G | 0.62889364 |
84 | MAPK13 | 0.62277667 |
85 | ROCK2 | 0.61836415 |
86 | DYRK1B | 0.61752019 |
87 | PDK3 | 0.60936888 |
88 | PDK4 | 0.60936888 |
89 | TNK2 | 0.60408434 |
90 | CDK14 | 0.59993373 |
91 | CASK | 0.59196484 |
92 | CSNK1G2 | 0.57985381 |
93 | CDK18 | 0.57365634 |
94 | MAP3K6 | 0.57355248 |
95 | MAPK7 | 0.57312874 |
96 | INSRR | 0.57233497 |
97 | CDK15 | 0.56716656 |
98 | SGK1 | 0.56504360 |
99 | MAPK10 | 0.56443477 |
100 | PRKG2 | 0.54918399 |
101 | CAMK2B | 0.54378362 |
102 | BRAF | 0.51699233 |
103 | RPS6KA2 | 0.51696980 |
104 | EPHB1 | 0.50041299 |
105 | SCYL2 | 0.49714855 |
106 | MAP3K5 | 0.49082217 |
107 | DAPK3 | 0.47231252 |
108 | CAMK4 | 0.46857286 |
109 | CDK11A | 0.46549213 |
110 | PRKD1 | 0.45796696 |
111 | IRAK2 | 0.45650027 |
112 | PKN1 | 0.44310167 |
113 | BMPR2 | 0.44147257 |
114 | MARK2 | 0.43860543 |
115 | RPS6KA3 | 0.43208493 |
116 | CAMK1G | 0.42808046 |
117 | FYN | 0.42374250 |
118 | PRKACG | 0.41848853 |
119 | TAOK2 | 0.41833444 |
120 | ICK | 0.41814227 |
121 | PRKCE | 0.40378963 |
122 | MAPK12 | 0.38269826 |
123 | CAMK2D | 0.37437847 |
124 | MAP3K11 | 0.36087855 |
125 | SIK1 | 0.35993711 |
126 | MAP2K6 | 0.35523653 |
127 | ALK | 0.34972302 |
128 | FGFR4 | 0.34141524 |
129 | JAK2 | 0.33445648 |
130 | ERN1 | 0.32827015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38454811 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71374183 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.55910044 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35286453 |
5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.18559514 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.09219084 |
7 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96986720 |
8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94710351 |
9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90625999 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74958225 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73712628 |
12 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.70784695 |
13 | Bile secretion_Homo sapiens_hsa04976 | 1.59750198 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.59645492 |
15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55734259 |
16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54544473 |
17 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54078973 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.47191040 |
19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.46570240 |
20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41376901 |
21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40794112 |
22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40365668 |
23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40168752 |
24 | Insulin secretion_Homo sapiens_hsa04911 | 1.40014329 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39489992 |
26 | Morphine addiction_Homo sapiens_hsa05032 | 1.38666262 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37049068 |
28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31862574 |
29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31576987 |
30 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.31471403 |
31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30998670 |
32 | Salivary secretion_Homo sapiens_hsa04970 | 1.30681951 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29382826 |
34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.28353246 |
35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26456154 |
36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24022958 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15093108 |
38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12039920 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11614585 |
40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10098768 |
41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08138742 |
42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06096154 |
43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05548345 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05254065 |
45 | Peroxisome_Homo sapiens_hsa04146 | 1.01547911 |
46 | Renin secretion_Homo sapiens_hsa04924 | 0.99476289 |
47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96167460 |
48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95116110 |
49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95066744 |
50 | Taste transduction_Homo sapiens_hsa04742 | 0.94341301 |
51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.92802648 |
52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.92609193 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91726114 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90329142 |
55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89010770 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85712236 |
57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84810921 |
58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81911606 |
59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81373981 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79792295 |
61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79327835 |
62 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78233154 |
63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76222127 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76081799 |
65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75357358 |
66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72843800 |
67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72810386 |
68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72150128 |
69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70736522 |
70 | Endocytosis_Homo sapiens_hsa04144 | 0.70464865 |
71 | Long-term depression_Homo sapiens_hsa04730 | 0.70373918 |
72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70236392 |
73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68809040 |
74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67681630 |
75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67660790 |
76 | Gap junction_Homo sapiens_hsa04540 | 0.66885450 |
77 | Axon guidance_Homo sapiens_hsa04360 | 0.66485332 |
78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66287060 |
79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65923214 |
80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65579250 |
81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64850987 |
82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64700598 |
83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64109567 |
84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63671590 |
85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62045774 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61941158 |
87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61666696 |
88 | Amoebiasis_Homo sapiens_hsa05146 | 0.61233919 |
89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61181239 |
90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61072756 |
91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60958211 |
92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60691296 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60656404 |
94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60391039 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59976593 |
96 | Prion diseases_Homo sapiens_hsa05020 | 0.59423401 |
97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58696207 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58468147 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57655583 |
100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56840735 |
101 | Mineral absorption_Homo sapiens_hsa04978 | 0.54985689 |
102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54768860 |
103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54559705 |
104 | Glioma_Homo sapiens_hsa05214 | 0.54479647 |
105 | Focal adhesion_Homo sapiens_hsa04510 | 0.54226985 |
106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54102101 |
107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53480924 |
108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53411273 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52544192 |
110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51387457 |
111 | ABC transporters_Homo sapiens_hsa02010 | 0.49342341 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47888336 |
113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47438138 |
114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47169152 |
115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47147373 |
116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46786573 |
117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46073019 |
118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45639376 |
119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45342855 |
120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45247431 |
121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44193370 |
122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43410488 |
123 | Lysosome_Homo sapiens_hsa04142 | 0.42581413 |
124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42338461 |
125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42148962 |
126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42139913 |
127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41745131 |
128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41459466 |
129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39709507 |
130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39560417 |
131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39445754 |
132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39362769 |
133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38958055 |
134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37253551 |
135 | Melanogenesis_Homo sapiens_hsa04916 | 0.36873532 |
136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36720776 |
137 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36658402 |
138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36439196 |
139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35859128 |